Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jul 12, 2021 10:15am
15 Views
Post# 33529392

RE:RE:2 years

RE:RE:2 years

Newcamo was around for years before 2019. He has changed names over the years. He's from around Montreal and has been using sur, u're and negociation gona and a bunch of other non-English short forms for years. Gives him away everytime! He certainly could be pumping while thomvest secretly and slowly withdraws every indication on every small molecule which appears to be happening with cessation of 4547 trial on NASH and cancellation of 4050 phase 2 trials on IPF and hyperglycademia. No mention of heart,
liver or kidney for 4050 phase 2 trials. Either 4050 as penicillin was a complete lie or they are tanking it to shut down business and sell privately to big pharma at table in 2018. That's the bet I have as Pritchard and Sartore are not there to grow and develop a small molecule business. Look at the deal that they made for Ryplazim - a giveaway after spending $500M over 4 years mostly on BLA for Ryplazim. Have to be pretty happy about that return on investment.

wyndewest wrote: PLITheOne is correct! I remeber Newcamo et al appeared just as Prometic was being highjacked by Thomvest (Peter Thomson) 2 years ago. I wonder how much Newcamo gets paid to continually spew MISINFORMATION that supports the Liminal takeover? It must be a lot to do this day after day (ie try to make investors think this stock is a good investment).  I think it is called 'pump and dump'. I think it is illegal? Why would Newcamo pump day after day, month after month. Perhaps he is being paid very well but only lowlife would do this....

 

<< Previous
Bullboard Posts
Next >>